---
title: Exploring public cancer gene expression signatures across bulk, single-cellÂ and
  spatial transcriptomics data with signifinder Bioconductor package
date: '2024-10-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39363890/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241005190914&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Understanding cancer mechanisms, defining subtypes, predicting prognosis
  and assessing therapy efficacy are crucial aspects of cancer research. Gene-expression
  signatures derived from bulk gene expression data have played a significant role
  in these endeavors over the past decade. However, recent advancements in high-resolution
  transcriptomic technologies, such as single-cell RNA sequencing and spatial transcriptomics,
  have revealed the complex cellular heterogeneity within tumors, ...
disable_comments: true
---
Understanding cancer mechanisms, defining subtypes, predicting prognosis and assessing therapy efficacy are crucial aspects of cancer research. Gene-expression signatures derived from bulk gene expression data have played a significant role in these endeavors over the past decade. However, recent advancements in high-resolution transcriptomic technologies, such as single-cell RNA sequencing and spatial transcriptomics, have revealed the complex cellular heterogeneity within tumors, ...